Buy SpaceX ahead of earnings, says Evercore ISI

Evercore ISI raised its SpaceX price target to $275 from $230, implying 85% upside from Thursday’s close, and maintained an outperform rating ahead of the company’s expected early-November Q3 results. LSEG-polled analysts expect EPS of $0.14 and revenue of $12.738 billion; Evercore expects revenue and EBITDA above consensus. The analyst highlighted potential 2027 catalysts including Starship satellite deployments, reuse proof points, and Musk’s target of launching the first Starmind AI satellites in 4Q27; shares are up about 13% over three months.

Analysis

The setup is less about one quarter’s reported EPS than whether SpaceX can convert technical milestones into a repeatable, lower-cost launch cadence. If reuse is demonstrated across clean flights, the second-order effect is potential pressure on competing launch economics and improved deployment capacity for SpaceX’s own satellite network. But a successful flight is not yet proof of commercial cadence: refurbishment time, reliability, regulatory approvals and actual launch frequency determine whether the cost curve changes.

The bullish case is already widely held, so an upbeat analyst note alone is unlikely to be a durable catalyst. The November print matters if it narrows uncertainty around revenue quality, EBITDA, capital intensity and cash generation; those details are not supplied here and should be verified rather than inferred from the headline estimates. Over 1–3 months, guidance and operating metrics can move sentiment. Over 6–18 months, Starship reuse and satellite deployments are the larger optionality, while orbital-compute claims remain feasibility questions, not an established revenue stream.

Contrarian risk: investors may credit Starship milestones before operational repeatability is demonstrated. A launch or regulatory setback could defer deployments and compress the value assigned to long-dated initiatives. Conversely, if execution is clean and cadence accelerates, consensus expectations may understate the strategic value of lower-cost internal launches. The broad analyst optimism and recent share strength argue against chasing ahead of measurable evidence.

Key Decisions for Investors

• Do not add exposure solely on the analyst upgrade. Ahead of the November report, treat SPCX as an event-risk position and verify segment-level revenue, EBITDA, capex/cash generation, launch cadence and any guidance changes; these are the missing data needed to judge whether the quarter improves the medium-term model.
• Use a post-earnings confirmation entry rather than a pre-print chase: consider a measured long only if reported operating metrics support improving economics and management provides credible cadence milestones. Reassess if the print or guidance weakens those measures, or if launch/regulatory delays undermine the next-flight timeline.
• For a defined-risk bullish expression, consider a call spread around the earnings catalyst only if option-implied volatility and spread pricing are reasonable; otherwise, wait until after the event. Avoid an outright short based only on crowded bullish sentiment, since successful reuse could re-rate the long-dated opportunity.
• Track Starship reuse, refurbishment interval, clean-flight sequence, regulatory approvals and satellite deployment milestones through 2027. Treat orbital-compute economics as unproven until deployment feasibility and commercial demand are evidenced; do not capitalize that optionality as near-term earnings.